Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Sells $80,198.68 in Stock

Integral Ad Science Holding Corp. (NASDAQ:IAS) CEO Lisa Utzschneider sold 8,044 shares of Integral Ad Science stock in a transaction that occurred on Monday, May 6th. The shares were sold at an average price of $9.97, for a total transaction of $80,198.68. Following the sale, the chief executive officer now owns 203,139 shares of the company’s stock, valued at $2,025,295.83. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.

Lisa Utzschneider also recently made the following trade(s):

• On Monday, April 8th, Lisa Utzschneider sold 30,407 shares of Integral Ad Science stock. The stock was sold at an average price of $10.05, for a total value of $305,590.35.

Integral Ad Science Trading Down 0.7 %

Shares of IAS stock opened at $9.90 on Wednesday. Integral Ad Science Holding Corp. has a twelve month low of $8.92 and a twelve month high of $20.88. The stock has a market cap of $1.58 billion, a price-to-earnings ratio of 248.81, a PEG ratio of 1.72 and a beta of 1.58. The company’s 50-day moving average price is $9.85 and its 200-day moving average price is $12.85. The company has a current ratio of 3.21, a quick ratio of 3.21 and a debt-to-equity ratio of 0.17.

Integral Ad Science (NASDAQ:IAS) last posted its quarterly earnings results on Tuesday, February 27th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.03 by $0.03. The business had revenue of $134.30 million during the quarter, compared to analysts’ expectations of $131.27 million. Integral Ad Science had a net margin of 1.53% and a return on equity of 0.83%. The business’s revenue for the quarter was up 14.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.07 EPS. As a group, equities analysts predict that Integral Ad Science Holding Corp. will post 0.16 earnings per share for the current year.

Analysts Set New Price Targets

A number of equities research analysts have recently commented on the stock. Raymond James cut shares of Integral Ad Science from a “strong-buy” rating to an “outperform” rating and dropped their price objective for the stock from $20.00 to $16.00 in a research note on Wednesday, February 28th. Oppenheimer dropped their target price on shares of Integral Ad Science from $25.00 to $20.00 and set an “outperform” rating on the stock in a research report on Wednesday, February 28th. BMO Capital Markets lowered their price objective on Integral Ad Science from $18.00 to $16.00 and set an “outperform” rating on the stock in a report on Wednesday, February 28th. Morgan Stanley restated an “equal weight” rating and issued a $12.00 target price (down previously from $18.00) on shares of Integral Ad Science in a research report on Tuesday, April 16th. Finally, Benchmark reiterated a “hold” rating on shares of Integral Ad Science in a research report on Tuesday. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $17.38.

Institutional Investors Weigh In On Integral Ad Science

Several hedge funds and other institutional investors have recently added to or reduced their stakes in IAS. Goldman Sachs Group Inc. lifted its stake in shares of Integral Ad Science by 605.1% in the 4th quarter. Goldman Sachs Group Inc. now owns 2,740,011 shares of the company’s stock valued at $39,429,000 after purchasing an additional 2,351,414 shares during the last quarter. abrdn plc acquired a new position in Integral Ad Science in the fourth quarter valued at about $25,285,000. Vanguard Group Inc. boosted its stake in Integral Ad Science by 15.2% during the third quarter. Vanguard Group Inc. now owns 7,325,778 shares of the company’s stock worth $87,104,000 after buying an additional 966,280 shares during the period. P2 Capital Partners LLC purchased a new position in Integral Ad Science during the fourth quarter worth about $11,144,000. Finally, TimesSquare Capital Management LLC increased its position in shares of Integral Ad Science by 32.2% during the third quarter. TimesSquare Capital Management LLC now owns 2,486,748 shares of the company’s stock valued at $29,567,000 after acquiring an additional 605,824 shares during the last quarter. Institutional investors and hedge funds own 95.78% of the company’s stock.

About Integral Ad Science

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.